See this article:
September 5, 2011, Medical News Today
Other news at http://www.cmleukemia.com/english.html
Posted 11 September 2011 - 08:05 AM
Interesting articles, cousineg, thanks for posting the links. I was particularly interested in the Novartis/India patent story.
"You can't change the direction of the wind but you can adjust your sails."
DX 12/08; Gleevec 400mg; liver toxicity; Sprycel 100mg.; CCyR 4/10; MMR 8/10; Pleural Effusion 2/12; Sprycel 50mg. Maintaining MMR; 2/15 PCRU; 8/16 drifting in and out of undetected like a wave meeting the shore. Retired 12/23/2016! 18 months of PCRU, most recent at Mayo on 7/25/17 was negative at their new sensitivity reporting of 0.003.<p>
0 members, 1 guests, 0 anonymous users